A break from treatment with Vtama won’t lead to worsening of patients’ atopic dermatitis, finds a new analysis of an ...

Corticosteroids are probably the most effective at decreasing the inflammation but carry significant risks for side effects, particularly if used systemically. Topical and intralesional ...

The mucus comes from the conjunctiva which is the transparent tissue covering the whites of the eye and internal surface of ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...

The global canine atopic dermatitis market is experiencing significant growth, projected to escalate from US$ 231.4 Mn in ...

Amgen and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell ...

Corticosteroids ... efficacy as well as low side effect profile, it is a popular treatment choice. Calcipotriene is not associated with many of the local adverse effects that are seen with ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...

All interviewers were trained in gathering qualitative information. The interviews explored personal experiences with topical steroids, side effects, changing perceptions and interactions with ...

Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMDARTEMIS ...